Article

Pharmacy Clinical Pearl of the Day: PrEP for HIV

Truvada is a medicine people at risk for HIV should take to prevent infection with the virus from various ways, such as sex or injection drug use.

Clinical Pearl of the Day: PrEP for HIV

  • Emtricitabine and tenofovir disoproxil fumarate (Truvada) for pre-exposure prophylaxis (PrEP) is a once-daily prescription medicine for adults and adolescents at risk of HIV who weigh at least 77 pounds.

Explanation

  • Truvada is a medicine people at risk for HIV should take to prevent infection with the virus from various ways, such as sex or injection drug use.
  • PrEP consists of a combination of 2 antiretroviral drugs (tenofovir and emtricitabine), usually taken daily and often in combination with other HIV medicines.
  • When taken consistently, the Centers for Disease Control and Prevention estimates that PrEP reduces the risk of HIV infection by up to 92%.

Reference

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com